Hsin-Fu Lee

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Acute Myocardial Infarction

Coronary Artery Bypass Grafting

Cardiovascular Events

Top Venues

Clinical pharmacology and therapeutics

Diabetes, obesity & metabolism

Cardio-oncology (London, England)

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jian-Rong Peng, Jason Chia-Hsun Hsieh, Chih-Hao Chang, Chi Chuang, Yu-Ching Wang, Tzu-Yang Chen, Hung-Chi Su, Hsin-Fu Lee
Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study. Cardio-oncology (London, England) 10 (1) (2024)
Hsin-Fu Lee, Yi-Hsin Chan, Tzyy-Jer Hsu, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Hung-Chi Su, Fu-Chih Hsiao, Lai-Chu See
Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Non-Users. Clinical pharmacology and therapeutics (2024)
Hsin-Fu Lee, Yi-Hsin Chan, Tzyy-Jer Hsu, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Hung-Chi Su, Fu-Chih Hsiao, Lai-Chu See
Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Non-Users. Clinical pharmacology and therapeutics 116 (2) (2024)
Tzu-Yang Chen, Hsin-Fu Lee, Yi-Hsin Chan, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Hung-Chi Su, Lai-Chu See
Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium-glucose cotransporter 2 inhibitors users versus non-users. A propensity score matching National Cohort Study. Diabetes, obesity & metabolism (2024)
Hsin-Fu Lee, Yi-Hsin Chan, Tzyy-Jer Hsu, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Hung-Chi Su, Fu-Chih Hsiao, Lai-Chu See
Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Non-Users. Clinical pharmacology and therapeutics 116 (2) (2024)
Hsin-Fu Lee, Yi-Hsin Chan, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Fu-Chih Hsiao, Jian-Rong Peng, Lai-Chu See
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors. European heart journal. Cardiovascular pharmacotherapy (2023)
Hsin-Fu Lee
Reconsidering the Timing of Aortic Valve Replacement in Symptomatic Normal-Flow Low-Gradient Severe Aortic Stenosis. Korean circulation journal (2023)
Hsin-Fu Lee, Lai-Chu See, Yi-Hsin Chan, Yung-Hsin Yeh, Lung-Sheng Wu, Jia-Rou Liu, Hui-Tzu Tu, Chun-Li Wang, Chi-Tai Kuo, Shang-Hung Chang
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study. Internal medicine journal 48 (9) (2019)